当前位置: 首页 >> 检索结果
共有 5106 条符合本次的查询结果, 用时 1.9445335 秒

3641. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality.

作者: Binita M Kamath.;Nancy B Spinner.;Karan M Emerick.;Albert E Chudley.;Carol Booth.;David A Piccoli.;Ian D Krantz.
来源: Circulation. 2004年109卷11期1354-8页
Alagille syndrome (AGS) is a dominantly inherited multisystem disorder involving the liver, heart, eyes, face, and skeleton, caused by mutations in Jagged1. Intracranial bleeding is a recognized complication and cause of mortality in AGS. There are multiple case reports of intracranial vessel abnormalities and other vascular anomalies in AGS. The objective of this study was to characterize the nature and spectrum of vascular anomalies in AGS.

3642. The United States cardiovascular care deficit.

作者: Dean J Kereiakes.;James T Willerson.
来源: Circulation. 2004年109卷7期821-3页

3643. Cardiovascular manpower: the looming crisis.

作者: Robert O Bonow.;Sidney C Smith.
来源: Circulation. 2004年109卷7期817-20页

3644. Cardiology's workforce shortage: implications for patient care and research.

作者: W Bruce Fye.
来源: Circulation. 2004年109卷7期813-6页

3645. Evidence-based guidelines for cardiovascular disease prevention in women.

作者: Lori Mosca.;Lawrence J Appel.;Emelia J Benjamin.;Kathy Berra.;Nisha Chandra-Strobos.;Rosalind P Fabunmi.;Deborah Grady.;Constance K Haan.;Sharonne N Hayes.;Debra R Judelson.;Nora L Keenan.;Patrick McBride.;Suzanne Oparil.;Pamela Ouyang.;Mehmet C Oz.;Michael E Mendelsohn.;Richard C Pasternak.;Vivian W Pinn.;Rose Marie Robertson.;Karin Schenck-Gustafsson.;Cathy A Sila.;Sidney C Smith.;George Sopko.;Anne L Taylor.;Brian W Walsh.;Nanette K Wenger.;Christine L Williams.; .
来源: Circulation. 2004年109卷5期672-93页

3646. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.

作者: Nick E J West.;Peter N Ruygrok.;Clemens M C Disco.;Mark W I Webster.;Wietze K Lindeboom.;William W O'Neill.;Nestor F Mercado.;Patrick W Serruys.
来源: Circulation. 2004年109卷7期867-73页
Restenosis and consequent adverse cardiac events are increased in diabetics undergoing percutaneous coronary intervention. Use of intracoronary stents may ameliorate such risks; however, factors influencing the likelihood of restenosis after stent deployment in this high-risk patient subgroup are unknown.

3647. Evidence base for pacemaker mode selection: from physiology to randomized trials.

作者: Gervasio A Lamas.;Kenneth A Ellenbogen.
来源: Circulation. 2004年109卷4期443-51页

3648. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

作者: Scott M Grundy.;H Bryan Brewer.;James I Cleeman.;Sidney C Smith.;Claude Lenfant.; .; .
来源: Circulation. 2004年109卷3期433-8页

3649. Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment.

作者: Sanjiv Kaul.;Hiroshi Ito.
来源: Circulation. 2004年109卷3期310-5页

3650. Cardiac resynchronization therapy: helpful now in selected patients with CHF.

作者: James T Willerson.;Dean J Kereiakes.
来源: Circulation. 2004年109卷3期308-9页

3651. Cardiac resynchronization therapy: current state of the art: cost versus benefit.

作者: Angelo Auricchio.;William T Abraham.
来源: Circulation. 2004年109卷3期300-7页

3652. Ventricular resynchronization: current state of the art.

作者: Christophe Leclercq.;Joshua M Hare.
来源: Circulation. 2004年109卷3期296-9页

3653. Endothelial dysfunction in pulmonary hypertension.

作者: Rohit Budhiraja.;Rubin M Tuder.;Paul M Hassoun.
来源: Circulation. 2004年109卷2期159-65页

3654. Manipulating cardiac contractility in heart failure: data from mice and men.

作者: Gerald W Dorn.;Jeffery D Molkentin.
来源: Circulation. 2004年109卷2期150-8页

3655. Microvasculature in acute myocardial ischemia: part I: evolving concepts in pathophysiology, diagnosis, and treatment.

作者: Sanjiv Kaul.;Hiroshi Ito.
来源: Circulation. 2004年109卷2期146-9页

3656. Response to cardiac arrest and selected life-threatening medical emergencies: the medical emergency response plan for schools: A statement for healthcare providers, policymakers, school administrators, and community leaders.

作者: Mary Fran Hazinski.;David Markenson.;Steven Neish.;Mike Gerardi.;Janis Hootman.;Graham Nichol.;Howard Taras.;Robert Hickey.;Robert OConnor.;Jerry Potts.;Elise van der Jagt.;Stuart Berger.;Steve Schexnayder.;Arthur Garson.;Alidene Doherty.;Suzanne Smith.; .; .; .; .; .; .; .; .; .; .; .
来源: Circulation. 2004年109卷2期278-91页

3657. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system.

作者: Bernard I Lévy.
来源: Circulation. 2004年109卷1期8-13页

3658. Relative effects of air pollution on lungs and heart.

作者: Robert L Johnson.
来源: Circulation. 2004年109卷1期5-7页

3659. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?

作者: Prakash C Deedwania.
来源: Circulation. 2004年109卷1期2-4页

3660. Mechanical circulatory support for advanced heart failure: where does it stand in 2003?

作者: O H Frazier.;Reynolds M Delgado.
来源: Circulation. 2003年108卷25期3064-8页
共有 5106 条符合本次的查询结果, 用时 1.9445335 秒